Markets › United States › NAS › GDTC

CytoMed Therapeutics Ltd

NAS:GDTCHealthcarenasdaq_composite

$0.8799+1.14%At closeAt close · Sat 17 Oct · ≈ AED 3.23 · Market cap $10.41M · Next earnings Fri 13 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	—	—	−29.8%	99.3%	75.4%	−277.7%	—	—
Operating margin	—	—	−624.5%	−310.2%	−4,504.3%	−1,416.0%	−1,416.0%	+0.0 pts
Net margin	—	—	−835.7%	−814.0%	−3,621.1%	−1,227.1%	−1,227.1%	+0.0 pts
EBITDA margin	—	—	−403.1%	−763.6%	−2,862.7%	−1,346.0%	—	—
Return on equity	−407.1%	−79.8%	−518.1%	−36.8%	−28.1%	−59.8%	−57.1%	+2.7 pts
Return on assets	−50.8%	−34.0%	−58.2%	−33.4%	−25.0%	−49.1%	−49.1%	+0.0 pts
Return on capital employed	−121.6%	−36.7%	−214.0%	−13.5%	−33.1%	−62.1%	—	—
Debt / equity	6.3×	1.3×	7.2×	0.0×	0.1×	0.1×	0.1×	−4.5%
Debt / assets	78.1%	53.6%	80.7%	3.6%	4.6%	6.0%	—	—
Interest coverage	−12.6×	−9.8×	−18.7×	−31.3×	−154.1×	−219.7×	—	—
Current ratio	0.5×	1.1×	0.6×	14.1×	9.9×	5.2×	5.2×	+0.0%
Quick ratio	0.5×	1.0×	0.5×	13.1×	8.5×	3.7×	—	—
Cash ratio	0.3×	0.9×	0.4×	12.5×	8.2×	3.0×	3.0×	+0.0%
Asset turnover	0.0×	0.0×	0.1×	0.0×	0.0×	0.0×	—	—
Inventory turnover	0.0×	0.0×	0.2×	0.0×	0.0×	1.1×	—	—
Receivables turnover	—	—	—	—	3.7×	3.1×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—